Oramed Pharmaceuticals Inc. Insider Trading

ORMP

Last 12 months

Insiders sold $1.17M and bought nothing on the open market.

All of the selling was scheduled in advance under 10b5-1 plans. The last open-market buy by an executive or director was in Apr 2023.

Net open-market

−$1.17M

0 buys · 4 sales

Under a 10b5-1 plan

100%

of the value sold

Insiders who bought / sold

0 / 2

executives and directors

Last open-market buy

Apr 2023

Apr 4, 2023

Get an email when ORMP's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Oct 1	Avraham Gabay Chief Financial Officer	Sold10b5-1 plan	20,000	$4.51	90K	2.3%	Form 4
Oct 1	Joshua Hexter COO & Cbo	Sold10b5-1 plan	30,000	$4.51	135K	2.2%	Form 4
Jul 1	Joshua Hexter COO & Cbo	Sold10b5-1 plan	137,000	$4.46	611K	11%	Form 4
Jul 1	Avraham Gabay Chief Financial Officer	Sold10b5-1 plan	73,360	$4.51	331K	9.8%	Form 4

Oct 110b5-1 plan
Avraham Gabay
Chief Financial Officer · sold 20,000 at $4.51
90K
2.3% of stake
Oct 110b5-1 plan
Joshua Hexter
COO & Cbo · sold 30,000 at $4.51
135K
2.2% of stake
Jul 110b5-1 plan
Joshua Hexter
COO & Cbo · sold 137,000 at $4.46
611K
11% of stake
Jul 110b5-1 plan
Avraham Gabay
Chief Financial Officer · sold 73,360 at $4.51
331K
9.8% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ORMP, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ORMP

CompareIntrinsic value

RNXTRenovoRx Inc.

$1.31+1.55%40

DNTHDianthus Therapeutics Inc.

$85.81+3.76%10

CYCNCyclerion Therapeutics Inc.

$30.56-4.38%40

MCRBSeres Therapeutics, Inc.

$2.13+8.42%0

NWBONorthwest Biotherapeutics Inc.

$0.17-2.94%26

SCPXScorpius Holdings Inc.

$0.00+0.00%10

CPMDCannapharmaRx Inc.

$0.00+0.00%0

KRROKorro Bio Inc.

$16.62+4.79%10

Held by ETFs

ORMP is in 1 US ETF. The largest of them, with ORMP's weight in each:

iShares Micro-Cap ETFIWC0.04%of the fund

Spot a number that looks wrong? Check it in ORMP's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ORMP

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.